UB Paderborn / Katalog / Suche / in CDI

Differential effects of age at illness onset on verbal memory functions in antipsychotic-naïve schizophrenia patients aged 12–43 years

Psychological medicine, 2021-07, Vol.51 (9), p.1570-1580

2021

Volltextzugriff (PDF)

The relation between dopamine D2 receptor blockade and the brain reward system: a longitudinal study of first-episode schizophrenia patients

Psychological medicine, 2020-01, Vol.50 (2), p.220-228

2020

Volltextzugriff (PDF)

Circadian rest-activity rhythms during benzodiazepine tapering covered by melatonin versus placebo add-on: data derived from a randomized clinical trial

BMC psychiatry, 2016-10, Vol.16 (1), p.348-348, Article 348

2016

Volltextzugriff (PDF)

Glutamate Levels and Resting Cerebral Blood Flow in Anterior Cingulate Cortex Are Associated at Rest and Immediately Following Infusion of S-Ketamine in Healthy Volunteers

Frontiers in psychiatry, 2018-02, Vol.9, p.22-22

2018

Volltextzugriff (PDF)

Assessment of auditory sensory processing in a neurodevelopmental animal model of schizophrenia—Gating of auditory-evoked potentials and prepulse inhibition

Behavioural brain research, 2010-12, Vol.213 (2), p.142-147

2010

Volltextzugriff (PDF)

The relation between dopamine D 2 receptor blockade and the brain reward system: a longitudinal study of first-episode schizophrenia patients

Psychological medicine, 2020-01, Vol.50 (2), p.220-228

2020

Volltextzugriff (PDF)

Associations Between Cognitive Function and Levels of Glutamatergic Metabolites and Gamma-Aminobutyric Acid in Antipsychotic-Naïve Patients With Schizophrenia or Psychosis

Biological psychiatry (1969), 2021-02, Vol.89 (3), p.278-287

2021

Volltextzugriff (PDF)

Cerebral blood flow in striatum is increased by partial dopamine agonism in initially antipsychotic-naïve patients with psychosis

Psychological medicine, 2023-10, Vol.53 (14), p.6691-6701

2023

Volltextzugriff (PDF)

Objective and subjective sleep quality: melatonin versus placebo add-on treatment in patients with schizophrenia or bipolar disorder withdrawing from long-term benzodiazepine use

Psychiatry research, 2016-06, Vol.240, p.163-169

2016

Volltextzugriff (PDF)

Dopaminergic Activity in Antipsychotic-Naïve Patients Assessed With Positron Emission Tomography Before and After Partial Dopamine D2 Receptor Agonist Treatment: Association With Psychotic Symptoms and Treatment Response

Biological psychiatry (1969), 2022-01, Vol.91 (2), p.236-245

2022

Volltextzugriff (PDF)

Glucocorticoids and the risk of schizophrenia spectrum disorder in childhood and adolescence – A Danish nationwide study

Schizophrenia research, 2018-09, Vol.199, p.116-122

2018

Volltextzugriff (PDF)

Effects of Blocking D2/D3 Receptors on Mismatch Negativity and P3a Amplitude of Initially Antipsychotic Naïve, First Episode Schizophrenia Patients

The international journal of neuropsychopharmacology, 2016-03, Vol.19 (3), p.pyv109-pyv109

2016

Volltextzugriff (PDF)

Auditory sensory gating in young adolescents with early-onset psychosis: a comparison with attention deficit/hyperactivity disorder

Neuropsychopharmacology (New York, N.Y.), 2020-03, Vol.45 (4), p.649-655

2020

Volltextzugriff (PDF)

Heritability of cerebral glutamate levels and their association with schizophrenia spectrum disorders: a 1 [H]-spectroscopy twin study

Neuropsychopharmacology (New York, N.Y.), 2019-02, Vol.44 (3), p.581-589

2019

Volltextzugriff (PDF)

Striatal D 2/3 Binding Potential Values in Drug-Naïve First-Episode Schizophrenia Patients Correlate With Treatment Outcome

Schizophrenia bulletin, 2015-09, Vol.41 (5), p.1143-1152

2015

Volltextzugriff (PDF)

Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia—sub-chronic and early postnatal PCP treatment in attentional set-shifting

Psychopharmacologia, 2009-11, Vol.206 (4), p.631-640

2009

Volltextzugriff (PDF)

Using brain structural neuroimaging measures to predict psychosis onset for individuals at clinical high-risk

Molecular psychiatry, 2024-02, Vol.29 (5), p.1465-1477

2024

Volltextzugriff (PDF)

Cerebral Glutamate and Gamma-Aminobutyric Acid Levels in Individuals at Ultra-high Risk for Psychosis and the Association With Clinical Symptoms and Cognition

Biological psychiatry : cognitive neuroscience and neuroimaging, 2020-06, Vol.5 (6), p.569-579

2020

Volltextzugriff (PDF)

Dopamine Synthesis Capacity and GABA and Glutamate Levels Separate Antipsychotic-Naïve Patients With First-Episode Psychosis From Healthy Control Subjects in a Multimodal Prediction Model

Biological psychiatry global open science, 2023-07, Vol.3 (3), p.500-509

2023

Volltextzugriff (PDF)

Evaluation of a neurodevelopmental model of schizophrenia—Early postnatal PCP treatment in attentional set-shifting

Behavioural brain research, 2008-06, Vol.190 (1), p.160-163

2008

Volltextzugriff (PDF)

Cerebral glutamate and GABA levels in high-risk of psychosis states: A focused review and meta-analysis of 1H-MRS studies

Schizophrenia research, 2020-01, Vol.215, p.38-48

2020

Volltextzugriff (PDF)

Striatal D2/3 Binding Potential Values in Drug-Naïve First-Episode Schizophrenia Patients Correlate With Treatment Outcome

Schizophrenia bulletin, 2015-09, Vol.41 (5), p.1143-1152

2015

Volltextzugriff (PDF)

Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis

Translational psychiatry, 2022-07, Vol.12 (1), p.297-11, Article 297

2022

Volltextzugriff (PDF)

Supplementary data for a focused review and meta-analysis of 1H-MRS studies on cerebral glutamate and GABA levels in high-risk of psychosis states

Data in brief, 2020-02, Vol.28, p.104920, Article 104920

2020

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Differential effects of age at illness onset on verbal memory functions in antipsychotic-naïve schizophrenia patients aged 12–43 years

Effects of prenatal nutrient supplementation and early life exposures on neurodevelopment at age 10: a randomised controlled trial - the COPSYCH study protocol

The relation between dopamine D2 receptor blockade and the brain reward system: a longitudinal study of first-episode schizophrenia patients

Circadian rest-activity rhythms during benzodiazepine tapering covered by melatonin versus placebo add-on: data derived from a randomized clinical trial

Glutamate Levels and Resting Cerebral Blood Flow in Anterior Cingulate Cortex Are Associated at Rest and Immediately Following Infusion of S-Ketamine in Healthy Volunteers

Assessment of auditory sensory processing in a neurodevelopmental animal model of schizophrenia—Gating of auditory-evoked potentials and prepulse inhibition

The relation between dopamine D 2 receptor blockade and the brain reward system: a longitudinal study of first-episode schizophrenia patients

Associations Between Cognitive Function and Levels of Glutamatergic Metabolites and Gamma-Aminobutyric Acid in Antipsychotic-Naïve Patients With Schizophrenia or Psychosis

Cerebral blood flow in striatum is increased by partial dopamine agonism in initially antipsychotic-naïve patients with psychosis

Objective and subjective sleep quality: melatonin versus placebo add-on treatment in patients with schizophrenia or bipolar disorder withdrawing from long-term benzodiazepine use

Dopaminergic Activity in Antipsychotic-Naïve Patients Assessed With Positron Emission Tomography Before and After Partial Dopamine D2 Receptor Agonist Treatment: Association With Psychotic Symptoms and Treatment Response

Glucocorticoids and the risk of schizophrenia spectrum disorder in childhood and adolescence – A Danish nationwide study

Effects of Blocking D2/D3 Receptors on Mismatch Negativity and P3a Amplitude of Initially Antipsychotic Naïve, First Episode Schizophrenia Patients

Auditory sensory gating in young adolescents with early-onset psychosis: a comparison with attention deficit/hyperactivity disorder

Heritability of cerebral glutamate levels and their association with schizophrenia spectrum disorders: a 1 [H]-spectroscopy twin study

Striatal D 2/3 Binding Potential Values in Drug-Naïve First-Episode Schizophrenia Patients Correlate With Treatment Outcome

Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia—sub-chronic and early postnatal PCP treatment in attentional set-shifting

Using brain structural neuroimaging measures to predict psychosis onset for individuals at clinical high-risk

Cerebral Glutamate and Gamma-Aminobutyric Acid Levels in Individuals at Ultra-high Risk for Psychosis and the Association With Clinical Symptoms and Cognition

Dopamine Synthesis Capacity and GABA and Glutamate Levels Separate Antipsychotic-Naïve Patients With First-Episode Psychosis From Healthy Control Subjects in a Multimodal Prediction Model

Evaluation of a neurodevelopmental model of schizophrenia—Early postnatal PCP treatment in attentional set-shifting

Cerebral glutamate and GABA levels in high-risk of psychosis states: A focused review and meta-analysis of 1H-MRS studies

Striatal D2/3 Binding Potential Values in Drug-Naïve First-Episode Schizophrenia Patients Correlate With Treatment Outcome

Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis

Supplementary data for a focused review and meta-analysis of 1H-MRS studies on cerebral glutamate and GABA levels in high-risk of psychosis states

Suchergebnisse filtern